Literature DB >> 2013279

High-mobility-group proteins P1, I and Y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase.

L Meijer1, A C Ostvold, S I Walass, T Lund, S G Laland.   

Abstract

All dividing cells entering the M phase of the cell cycle undergo the transient activation of an M-phase-specific histone H1 kinase which was recently shown to be constituted of at least two subunits, p34cdc2 and cyclincdc13. The DNA-binding high-mobility-group (HMG) proteins 1, 2, 14, 17, I, Y and an HMG-like protein, P1, were investigated as potential substrates of H1 kinase. Among these HMG proteins, P1 and HMG I and Y are excellent substrates of the M-phase-specific kinase obtained from both meiotic starfish oocytes and mitotic sea urchin eggs. Anticyclin immunoprecipitates, extracts purified on specific p34cdc2-binding p13suc1-Sepharose and affinity-purified H1 kinase display strong HMG I, Y and P1 phosphorylating activities, demonstrating that the p34cdc2/cyclincdc13 complex is the active kinase phosphorylating these HMG proteins. HMG I and P1 phosphorylation is competitively inhibited by a peptide mimicking the consensus phosphorylation sequence of H1 kinase. HMG I, Y and P1 all possess the consensus sequence for phosphorylation by the p34cdc2/cyclincdc13 kinase (Ser/Thr-Pro-Xaa-Lys/Arg). HMG I is phosphorylated in vivo at M phase on the same sites phosphorylated in vitro by H1 kinase. P1 is phosphorylated by H1 kinase on sites different from the sites of phosphorylation by casein kinase II. The three thermolytic phosphopeptides of P1 phosphorylated in vitro by purified H1 kinase are all present in thermolytic peptide maps of P1 phosphorylated in vivo in proliferating HeLa cells. These phosphopeptides are absent in nonproliferating cells. These results demonstrate that the DNA-binding proteins HMG I, Y and P1 are natural substrates for the M-phase-specific protein kinase. The phosphorylation of these proteins by p34cdc2/cyclincdc13 may represent a crucial event in the intense chromatin condensation occurring as cells transit from the G2 to the M phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013279     DOI: 10.1111/j.1432-1033.1991.tb15850.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin.

Authors:  M Prymakowska-Bosak; T Misteli; J E Herrera; H Shirakawa; Y Birger; S Garfield; M Bustin
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Increased NUCKS expression is a risk factor for poor prognosis and recurrence in endometrial cancer.

Authors:  Tianbo Liu; Shu Tan; Ye Xu; Fanling Meng; Chang Yang; Ge Lou
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

Review 3.  The plant cell cycle in context.

Authors:  M R Fowler; S Eyre; N W Scott; A Slater; M C Elliott
Journal:  Mol Biotechnol       Date:  1998-10       Impact factor: 2.695

Review 4.  Cyclins and cyclin-dependent kinases: a biochemical view.

Authors:  J Pines
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

5.  Combined evaluation of the expression of NUCKS and Ki-67 proteins as independent prognostic factors for patients with gastric adenocarcinoma.

Authors:  Ming Yang; Xiaoxia Wang; Qi Zhao; Tianbo Liu; Guodong Yao; Wenhao Chen; Zhiwei Li; Xiaoyi Huang; Yanqiao Zhang
Journal:  Tumour Biol       Date:  2014-05-02

6.  Protein phosphatase 2A1 is the major enzyme in vertebrate cell extracts that dephosphorylates several physiological substrates for cyclin-dependent protein kinases.

Authors:  P Ferrigno; T A Langan; P Cohen
Journal:  Mol Biol Cell       Date:  1993-07       Impact factor: 4.138

7.  NUCKS1 overexpression is a novel biomarker for recurrence-free survival in cervical squamous cell carcinoma.

Authors:  Lina Gu; Bairong Xia; Lili Zhong; Yuan Ma; Lei Liu; Liping Yang; Ge Lou
Journal:  Tumour Biol       Date:  2014-05-13

8.  NUCKS overexpression in breast cancer.

Authors:  Yiannis Drosos; Mirsini Kouloukoussa; Anne Carine Østvold; Kirsten Grundt; Nikos Goutas; Dimitrios Vlachodimitropoulos; Sophia Havaki; Panagoula Kollia; Christos Kittas; Evangelos Marinos; Vassiliki Aleporou-Marinou
Journal:  Cancer Cell Int       Date:  2009-08-10       Impact factor: 5.722

9.  Structure and expression of a calcium-binding protein gene contained within a calmodulin-regulated protein kinase gene.

Authors:  M Collinge; P E Matrisian; W E Zimmer; R L Shattuck; T J Lukas; L J Van Eldik; D M Watterson
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

10.  Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene.

Authors:  M Friedmann; L T Holth; H Y Zoghbi; R Reeves
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.